Flixonase

How to order Flixonase

1. Find the drug you need on our site.
2. Pick a clinic. See the price.
3. Fill in a short health form.
4. A doctor reads your form.
5. If it is safe for you, they say yes.
6. Your order ships fast to your door.
7. It comes in a plain, sealed box.

Why use us? We compare UK clinics. We show you the price and how fast they ship. We do not sell drugs. We just help you find the best one for you.

Is it safe? Yes. All our clinics are UK-based. A real doctor reads each form. They will not sell to you if it is not safe for you.

Flixonase on Prescriptsy

Flixonase is described on Prescriptsy as independent product information.

Here you can understand how online consultation works, what medical checks partner clinics carry out, and which factors matter when comparing providers.

We do not sell medicines directly, but help users compare licensed healthcare partners on price, delivery speed, service quality, and overall trustworthiness.

Flixonase Aqueous Nasal Spray contains fluticasone propionate 50 micrograms per spray, an intranasal corticosteroid used to prevent and treat the symptoms of allergic rhinitis (both seasonal hay fever and perennial nasal allergy).

It is one of the most widely used and clinically effective treatments for nasal allergy symptoms in the United Kingdom.

Flixonase relieves nasal congestion, sneezing, runny nose, nasal itching, and the associated eye symptoms (itchy, watering eyes) that commonly accompany allergic rhinitis.

It is available as a pharmacy (P) medicine for adults aged 18 and over (purchasable from a pharmacy without a prescription) and on prescription for adults and children aged 4 years and over.

Allergic rhinitis is one of the most prevalent chronic conditions in the United Kingdom, affecting an estimated 10 to 30% of adults and up to 40% of children.

Seasonal allergic rhinitis (hay fever) is triggered by windborne pollen from grasses, trees, and weeds, while perennial allergic rhinitis is caused by year-round allergens such as house dust mites, pet dander, and mould spores.

Although often dismissed as a minor condition, allergic rhinitis can significantly impair quality of life, affecting sleep, concentration, productivity at work and school, and participation in outdoor activities.

Poorly controlled rhinitis is also associated with worsening of coexisting asthma and increased risk of sinusitis and middle ear disease.

This page provides a comprehensive clinical overview of Flixonase, including how fluticasone propionate works, who should use it, application guidance, potential side effects, important safety information, and how to obtain it in the United Kingdom.

Important safety information about Flixonase

• Flixonase works best when used regularly. Full effect may take 3 to 4 days.
• Do not exceed the recommended dose without medical advice.
• Direct the spray away from the nasal septum to reduce the risk of nosebleeds.
• If you use other corticosteroid medicines (inhalers, creams, or eye drops), discuss total steroid exposure with your prescriber or pharmacist.
• Seek immediate medical attention if you experience signs of a severe allergic reaction.

Understanding allergic rhinitis

Allergic rhinitis occurs when the immune system mounts an inappropriate response to inhaled allergens.

In sensitised individuals, initial exposure to an allergen (such as grass pollen or house dust mite protein) triggers the production of allergen-specific immunoglobulin E (IgE) antibodies.

These IgE molecules bind to mast cells in the nasal mucosa.

On subsequent allergen exposure, the allergen cross-links surface-bound IgE, triggering mast cell degranulation and the release of histamine, leukotrienes, prostaglandins, and other inflammatory mediators.

This produces the immediate-phase allergic response: sneezing, itching, rhinorrhoea, and congestion within minutes of exposure.

Over the following 4 to 8 hours, a late-phase inflammatory response develops, driven by recruitment of eosinophils, basophils, and T-helper 2 (Th2) lymphocytes to the nasal mucosa.

This late-phase response causes sustained nasal congestion, mucus hypersecretion, and mucosal thickening.

With repeated allergen exposure (as occurs throughout the pollen season or in perennial rhinitis), chronic inflammation develops, leading to nasal hyperreactivity, whereby the nose becomes oversensitive to both allergic and non-allergic triggers such as cold air, strong odours, and changes in temperature.

Antihistamines (such as cetirizine, loratadine, and fexofenadine) primarily target the histamine-mediated early-phase response and are effective for sneezing, itching, and rhinorrhoea.

However, they have limited efficacy for nasal congestion, the symptom that patients often find most troublesome.

Intranasal corticosteroids such as fluticasone propionate are more effective than antihistamines for congestion because they suppress both the early- and late-phase inflammatory responses and address the underlying chronic mucosal inflammation.

How Flixonase works: mechanism of action

Fluticasone propionate is a potent, synthetic glucocorticoid with high topical anti-inflammatory activity and very low systemic bioavailability.

When deposited on the nasal mucosa, it is absorbed into epithelial cells, where it binds to intracellular glucocorticoid receptors.

The activated receptor-drug complex translocates to the cell nucleus and modulates gene transcription, upregulating anti-inflammatory proteins and downregulating the production of pro-inflammatory mediators.

Specifically, fluticasone propionate reduces the synthesis and release of histamine, leukotrienes, prostaglandins, and cytokines (including IL-4, IL-5, and IL-13, which are central to the Th2-driven allergic response).

It stabilises mast cells, reducing degranulation and histamine release. It inhibits eosinophil infiltration into the nasal mucosa. It reduces mucosal oedema by decreasing vascular permeability.

And it suppresses mucus gland hypersecretion.

The net result is a comprehensive reduction in all the cardinal symptoms of allergic rhinitis: sneezing, itching, rhinorrhoea, congestion, and associated eye symptoms.

Systemic absorption of fluticasone propionate from the nasal spray is less than 2%, because the small amount that is swallowed undergoes near-complete first-pass hepatic metabolism.

At recommended doses (100 to 200 micrograms daily), fluticasone propionate nasal spray does not suppress the hypothalamic-pituitary-adrenal (HPA) axis and does not produce the systemic side effects associated with oral corticosteroids.

Clinical evidence and UK prescribing guidance

Fluticasone propionate nasal spray has been studied extensively in randomised controlled trials involving thousands of patients with both seasonal and perennial allergic rhinitis.

It has consistently demonstrated significant improvements in total nasal symptom scores (sneezing, rhinorrhoea, congestion, itching) and ocular symptom scores compared with placebo.

Systematic reviews and meta-analyses have confirmed that intranasal corticosteroids as a class are the most effective single pharmacological intervention for allergic rhinitis, superior to oral antihistamines, leukotriene receptor antagonists, and intranasal antihistamines for overall symptom control, particularly nasal congestion.

NICE Clinical Knowledge Summary (CKS) on allergic rhinitis recommends intranasal corticosteroids as first-line treatment for moderate-to-severe or persistent symptoms, or as add-on therapy when oral antihistamines alone provide insufficient relief.

The British Society for Allergy and Clinical Immunology (BSACI) guideline on rhinitis makes similar recommendations, positioning intranasal corticosteroids as the treatment of choice for congestion-predominant rhinitis and for patients with multiple nasal and ocular symptoms.

Several intranasal corticosteroids are available in the UK, including fluticasone propionate (Flixonase, Avamys/fluticasone furoate), beclometasone (Beconase), mometasone (Nasonex), budesonide, and triamcinolone.

All are effective, though fluticasone propionate and mometasone have the highest topical potency and lowest systemic bioavailability, offering an optimal therapeutic ratio.

Flixonase compared with other nasal sprays

Beconase (beclometasone dipropionate) is the most commonly purchased over-the-counter nasal steroid spray in the UK.

It is effective for mild to moderate hay fever but has slightly higher systemic bioavailability than fluticasone propionate.

Flixonase (fluticasone propionate) has a more potent local anti-inflammatory effect and lower systemic absorption, making it a good choice for patients who need robust symptom control with minimal systemic steroid exposure.

Avamys (fluticasone furoate) is a related but distinct molecule with once-daily dosing and excellent patient satisfaction scores; it requires a prescription.

Nasonex (mometasone furoate) is another potent option available on prescription.

Antihistamine nasal sprays (such as azelastine, available as Rhinolast or in combination with fluticasone as Dymista) offer rapid onset of action and are effective for sneezing and itching but are less effective than corticosteroid sprays for congestion.

Dymista (azelastine plus fluticasone propionate) combines both mechanisms in a single spray and has been shown to provide superior symptom relief compared with either component alone.

How to use Flixonase nasal spray

Shake the bottle gently before use.

If using for the first time or after a gap of 7 or more days, prime the spray by pumping until a fine mist appears.

Blow your nose gently to clear the nasal passages. Hold the bottle upright with your thumb at the base and two fingers on the shoulder of the bottle.

Close one nostril with your finger. Insert the nozzle into the other nostril, aiming slightly away from the nasal septum (the central wall of the nose).

Press down on the pump while breathing in gently through your nose. Breathe out through your mouth. Repeat for the other nostril.

Wipe the nozzle with a clean tissue and replace the cap.

Use Flixonase at the same time each day for best results.

Many people prefer to use it in the morning, but it can be taken at any time that suits your routine.

For hay fever, begin treatment a few days before the start of your pollen season if possible, as it may take 3 to 4 days for full effect to develop.

Side effects of Flixonase

Common side effects

The most common side effects are nosebleeds (epistaxis), nasal dryness or irritation, unpleasant taste, headache, and sneezing immediately after spraying.

Nosebleeds are usually mild and are more likely with prolonged use, in dry environments, or if the spray is directed at the nasal septum.

Using a saline nasal spray or gel alongside Flixonase can help keep the nasal lining moist and reduce the frequency of nosebleeds.

Uncommon and rare side effects

Uncommon effects include hypersensitivity reactions (rash, facial swelling). Very rare effects include anaphylaxis and nasal septal perforation (a hole in the cartilage dividing the nose), which is associated with prolonged, high-dose use and improper spray technique.

At recommended doses, systemic side effects are extremely unlikely.

However, prolonged use at high doses, particularly in combination with other corticosteroid preparations, may theoretically contribute to adrenal suppression, osteoporosis, glaucoma, and cataracts.

These risks are very low with intranasal use alone.

When to seek medical advice

Contact your GP or call NHS 111 if you experience persistent or frequent nosebleeds, facial pain suggesting sinusitis, or any new symptoms that concern you.

Call 999 if you develop signs of a severe allergic reaction (breathing difficulty, swelling of the face or throat).

Report suspected adverse reactions to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk .

Warnings and precautions

Contraindications

Flixonase is contraindicated in patients with known hypersensitivity to fluticasone propionate, benzalkonium chloride, or any other excipient in the formulation.

Nasal conditions

Do not use Flixonase if you have recently had nasal surgery, nasal trauma, or have nasal ulcers, as corticosteroids may delay wound healing. Wait until healing is complete.

If you have an active nasal infection (bacterial, fungal, or viral, including herpes simplex), treat the infection first before starting Flixonase.

Combined corticosteroid use

If you use other corticosteroid medicines (inhaled corticosteroids for asthma, topical creams for skin conditions, or corticosteroid eye drops), the total systemic corticosteroid exposure should be considered. Discuss all your medications with your prescriber or pharmacist.

CYP3A4 interactions

Fluticasone propionate is metabolised by CYP3A4. Potent CYP3A4 inhibitors, particularly ritonavir (used in HIV treatment), can dramatically increase systemic fluticasone levels, leading to Cushing syndrome and adrenal suppression.

Co-administration with ritonavir is not recommended. Other potent CYP3A4 inhibitors (ketoconazole, itraconazole, cobicistat) should be used with caution alongside fluticasone.

Children

Flixonase is licensed for children aged 4 years and over on prescription. Long-term use in children should include monitoring of height, as intranasal corticosteroids may theoretically affect growth, though clinical studies have not demonstrated a significant effect at standard doses.

Pregnancy and breastfeeding

Intranasal corticosteroids are generally considered safe at recommended doses during pregnancy. NICE CKS advises that they may be used when antihistamines alone are insufficient.

Beclometasone nasal spray has the longest pregnancy safety record. Fluticasone propionate nasal spray may also be used after discussion with your GP or midwife.

Use during breastfeeding is considered acceptable at recommended doses due to negligible systemic absorption.

How to get Flixonase in the UK

Flixonase Allergy nasal spray is available as a pharmacy (P) medicine for adults aged 18 and over.

You can purchase it from any pharmacy in the UK after a brief consultation with the pharmacist to confirm suitability. No prescription is needed for adults.

For children aged 4 to 11 years, Flixonase requires a prescription from a GP or an authorised online prescriber registered with the General Pharmaceutical Council (GPhC).

The NHS prescription charge in England is currently 9.90 pounds per item; prescriptions are free in Scotland, Wales, and Northern Ireland.

Generic fluticasone propionate nasal sprays are also available at lower cost.

Living with allergic rhinitis: practical advice alongside Flixonase

Flixonase is most effective when used as part of a comprehensive allergy management strategy.

Practical measures to reduce allergen exposure during pollen season include monitoring pollen forecasts (Met Office, BBC Weather), keeping windows and doors closed on high pollen days, showering and changing clothes after spending time outdoors, wearing wraparound sunglasses, drying laundry indoors, and avoiding cutting grass or sitting in grassy areas.

For perennial rhinitis triggered by house dust mites, measures include using allergen-proof mattress and pillow covers, washing bedding at 60 degrees Celsius weekly, reducing humidity, and minimising soft furnishings and carpets in the bedroom.

Nasal saline irrigation (using a neti pot or saline spray) can be a useful adjunct to Flixonase, helping to clear allergens and mucus from the nasal passages.

If symptoms are not fully controlled by Flixonase alone, adding an oral antihistamine (cetirizine, loratadine, or fexofenadine) can provide additional relief, particularly for ocular and systemic allergy symptoms.

Sources

• Flixonase Aqueous Nasal Spray, Summary of Product Characteristics (EMC)
• Fluticasone (nasal), British National Formulary (BNF)
• NICE CKS: Allergic rhinitis
• Allergic rhinitis, NHS
• BSACI Guideline: Rhinitis
• MHRA Yellow Card Scheme